Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients by Anussara Prayongrat, Patjaya Noppaving, Thitiporn Chobarporn, Natthinee Sudhinaraset, Nattaya Teeyapun, Nussara Pakvisal, Watsamon Jantarabenjakul, Jiratchaya Sophonphan, Chawalit Lertbutsayanukul, Yong Poovorawan

Get full text

Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac by Passakorn Wanchaijiraboon, Panot Sainamthip, Nattaya Teeyapun, Sutima Luangdilok, Yong Poovorawan, Nasamon Wanlapakorn, Suebpong Tanasanvimon, Virote Sriuranpong, Thiti Susiriwatananont, Nicha Zungsontiporn, Nussara Pakvisal

Get full text

Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy cont... by Nussara Pakvisal, Panot Sainamthip, Nattaya Teeyapun, Sutima Luangdilok, Nassamon Wanlapakorn, Ritthideach Yorsaeng, Yong Poovorawan, Piyapoom Pakvisal, Thiti Susiriwatananont, Nicha Zungsontiporn, Virote Sriuranpong, Suebpong Tanasanvimon, Passakorn Wanchaijiraboon

Get full text

Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine by Sutima Luangdilok, Passakorn Wanchaijiraboon, Nussara Pakvisal, Thiti Susiriwatananont, Nicha Zungsontiporn, Virote Sriuranpong, Panot Sainamthip, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Nattaya Teeyapun, Suebpong Tanasanvimon

Get full text

Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment by Passakorn Wanchaijiraboon, Nattaya Teeyapun, Nussara Pakvisal, Panot Sainamthip, Thiti Susiriwatananont, Nicha Zungsontiporn, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Worata Klinsawat, Nasamon Wanlapakorn, Suebpong Tanasanvimon, Virote Sriuranpong, Yong Poovorawan, Sutima Luangdilok

Get full text

Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study by Nattaya Teeyapun, Sutima Luangdilok, Nussara Pakvisal, Panot Sainamthip, Siyamol Mingmalairak, Nattaya Poovorawan, Piyada Sitthideatphaiboon, Napa Parinyanitikul, Virote Sriuranpong, Teerayuth Namkanisorn, Pratchaya Inthasuwan, Pattama Angspatt, Ploytuangporn Wongchanapat, Akradach Bamrungnam, Nutchanok Leeleakpai, Sutheera Uttha, Supaporn Jaichum, Peerawich Kongkaew, Chayanin Suksanong, Rattiya Veranitinun, Ampai Prasomphol, Chada Sartsuk, Cheeraporn Patcharajutanon, Supreeya Preaprang, Hathairat Choengsamor, Rungthong Phongwan, Charoenpit Preeyasaksa, Ekkamol Phaibulvatanapong, Nungruthai Suntronwong, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Stephen J. Kerr, Yong Poovorawan, Passakorn Wanchaijiraboon, Suebpong Tanasanvimon

Get full text